CanNordic a/s: Financial statements 2014
CVR: 33871902
Source: annual report 2014, Danish Business Authority
01/10/2013 – 30/09/2014
CanNordic a/s (CVR 33871902) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 158,882 and a net result of DKK -39,138 compared with DKK 89,169 the year before. That is a decrease of 51.1% compared with the year before. Equity in the 2014 report amounted to DKK 85,915. The solvency ratio was 9%.
- Gross Profit
- DKK 158,882
- Profit/Loss
- DKK -39,138
- Equity
- DKK 85,915
- Total Assets
- DKK 957,563
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 159 t. | -39 t. | 86 t. | - |
| 2013 | - | 325 t. | 89 t. | 125 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of September 5, 2014, CS MEDICA a/s is registered as an owner of CanNordic a/s with an ownership share of 100%.
As of August 29, 2014, Niels Erik Schønberg has stepped down as director of CanNordic a/s.
CanNordic a/s has published its annual report for 2013. Gross profit came to DKK 324,932, and the net result was DKK 89,169.
About CanNordic a/s
CanNordic a/s is a Danish company of the type Aktieselskab based in København Ø, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named GALAXA PHARMA ApS. The management consists of Lone Henriksen. The board consists of Gitte Henriksen, Jens Jørgen Hagelskjær and Lone Henriksen. The company is owned by CS MEDICA a/s. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK -100,395 and a net result of DKK -6,219,720 compared with DKK -4,881,640 the year before. Equity in the 2025 report amounted to DKK 4,298,968.